Trial NCT04414631

View at ClinicalTrials.gov 
Org. Study IDs: 2020-01252; me20Osthoff3

Last trial update was posted on 2021-11-09

MeSH Interventions

Complement C1 Inhibitor Protein

MeSH Conditions

COVID-19 Communicable Diseases Coronavirus Infections Infections

Other Conditions


Stopping Reasons

Aim to enroll 120 patients deemed not sufficient to show a difference in the primary outcome measure. Standard of care treatment recently changed in Switzerland adding further heterogeneity to trial population when including future participants.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID